The Refining Ovarian Cancer Test Accuracy Scores (ROCkeTS) study, a large ongoing prospective study in the UK evaluating a range of diagnostic tests and algorithms for ovarian cancer in secondary care, may provide insight into the most appropriate post-CA125 testing strategy [37]. Here, MUC16 is linked to ovarian carcinoma.